Navigation Links
American Lung Association Encourages Awareness of Underutilized Lung Cancer Testing Option through ‘Tell a Friend about Tumor Testing’
Date:1/9/2017

As part of its ongoing dedication to providing the best information and support to patients with lung cancer, the American Lung Association is sharing information about precision medicine by launching the “Tell a Friend about Tumor Testing” initiative. Precision medicine is a rapidly evolving field that is bringing new hope to people with cancer, including lung cancer, the leading cancer killer in America. Through “Tell a Friend about Tumor Testing,” the Lung Association is raising awareness and urging lung cancer patients to talk to their doctor about tumor testing.

Delivering precision medicine involves testing tumor tissue for mutations in its DNA and levels of specific proteins in the tumor. These tests are sometimes called biomarker, molecular, genomic or tumor testing. If doctors know exactly what causes the tumor to grow, a patient may be able take a "targeted" or precision therapy that can slow tumor growth or shrink the tumor, or the patient could benefit from an immunotherapy treatment which uses the power of the immune system to fight the cancer.

Understanding what causes tumor growth and what can help stop or slow that growth, is critical in determining which treatments are best. To identify the makeup of a patient’s tumor, comprehensive genomic testing or genomic profiling, which tests for a wide range of biomarkers needs to be conducted. Testing can give healthcare providers key insights about which targeted therapy, immunotherapy or ongoing clinical trial might be most appropriate. Often even markers that do not yet have an approved treatment can provide potentially valuable information, given the pace of new drug discoveries and approvals.

“Lung cancer treatment was once essentially a one-size-fits-all approach,” said American Lung Association National President and CEO Harold P. Wimmer. “But no two lung cancers are exactly the same, and they shouldn’t be treated that way. Unfortunately, not all patients who are eligible for tumor testing receive it and few may be aware it’s available, so we’re urging people to spread the word. If you have a friend or know someone who has lung cancer, tell them about tumor testing, and urge them to talk to their doctor about getting their tumor tested.”

The American Lung Association’s “Tell a Friend about Tumor Testing” initiative is led by the lung cancer community itself, according to Wimmer. The Lung Association will amplify the voices of LUNG FORCE Heroes, a group of patients and caregivers touched by lung cancer, to convey not only the importance of tumor testing, but also how it affected the course of their life.

“Tell a Friend about Tumor Testing” is not only about building awareness, but also about educating lung cancer patients about the ins and outs of tumor testing. Resources include a video (http://bit.ly/2fToTv4) featuring LUNG FORCE Heroes Lisa and Jennifer and lung cancer pathologist Dr. Mark Pool, as well as an in-depth downloadable brochure. The Lung Association and its partners are asking the lung cancer community to raise awareness by sharing these resources, along with related Lung Association social media posts, and joining the “Tell a Friend about Tumor Testing” Twitter Thunderclap (https://www.thunderclap.it/projects/50194-tell-a-friend-tumor-testing) on January 11, 2017.

“Tell a Friend about Tumor Testing” is made possible through generous support from AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., and Novartis.

“It is important that as lung cancer testing and treatment advances are made, we help educate and engage the community and increase access to these treatments. Our hope is that one day all lung cancer patients get the best available treatment options for them, and campaigns like ‘Tell a Friend about Tumor Testing’ help move us closer to that goal,” Wimmer said.

For media interested in speaking with an expert about lung cancer, tumor testing and lung health, contact Allison MacMunn at Media(at)Lung(dot)org or 312-801-7628.

Read the full story at http://www.prweb.com/releases/2016/12/prweb13944627.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. The "30 Minute Body" Book Remedies & Exposes The Health Industries Misleading Information to Americans
2. American Couple Enjoy a Volunteer Abroad Project and Wildlife Safari in Africa
3. Sigma Theta Tau International Publishing Honored by the American Journal of Nursing with Five Book of the Year Awards
4. Jerry Schumacher Named FloTrack American Distance Coach of the Year
5. HSN Invites Entrepreneur, Nick Batsikouras, to Launch as Part of its American Dreams initiative, The World's Smartest Nutritional Food Scale: The Smart Diet Scale.
6. American Knife & Tool Institute Comments on Prefiling of Virginia House Bill 1432
7. Surgeon General Reports 20.8M Americans Misuse Drugs; Novus Medical Detox Center Analyzes Costs
8. Brenntag Specialties, Inc. (BSI), Brenntag Canada Announce Partnership with Chr. Hansen A/S for Distribution of Natural Colors for North American Food and Beverage Market
9. Z-Medica Teams Up with the American College of Surgeons Providing Basic Bleeding Control Instructor Training
10. Greenberg Traurig’s Lori Cohen and Sara Thompson to Speak at American Conference Institute’s Drug & Medical Device Litigation Conference
11. Mediaplanet Announces Their Collaboration With the American Heart Association, Cleveland Clinic, Maks Chmerkovskiy and More for the New "Cardiovascular Health" Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2019)... ... April 18, 2019 , ... ... workshop presentations at the upcoming Global Clinical Supplies Group (GCSG) 2019 US Annual ... on April 28 – May 1, 2019. , Erin Vlack, Project Manager, will ...
(Date:4/18/2019)... ... April 18, 2019 , ... Swiss Pet company ... is designed to support the bond between human and animal while improving the overall ... certified Swiss herbal specialists with decades of experience. They are made by hand from ...
(Date:4/18/2019)... ... April 18, 2019 , ... Governor Phil ... of areas. This year’s bill proposed several updates to Vermont’s leading captive law, ... group captive investments. The many enhancements included in this year’s bill highlight the ...
(Date:4/18/2019)... ... , ... She went from learning disabled to honor roll – all because ... Those “goofy tests,” performed by Deborah Zelinsky, O.D. , founder of the Mind-Eye ... narrow range of visual awareness, she could only see what was directly in front ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... best provider for their care. Through the rise of online review sites and ... of interaction and transparency when making important purchasing decisions online. In order to ...
Breaking Medicine News(10 mins):
(Date:4/17/2019)... ATLANTA, Ga. (PRWEB) , ... April 17, 2019 ... ... solutions to healthcare providers and patients, announced today it has completed the acquisition ... Founded in 2012, Omni Holdings is the leading medical lien funding company operating ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... Allegheny Health Network (AHN) and Gateway Health have launched a new program that ... life. , AHN’s Enhanced Pain Management Program brings together a range of ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... Efficient Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics’ ... sites alike. , Through years of experience helping sponsors manage complex oncology ...
Breaking Medicine Technology: